GSA Capital Partners’s BioXcel Therapeutics BTAI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,658	Closed	-$350K	–	1535
2022 Q2	$350K	Buy	+1,658	New	+$350K	0.05%	724
2021 Q4	–	Sell	-3,709	Closed	-$1.8M	–	1430
2021 Q3	$1.8M	Buy	+3,709	New	+$1.8M	0.18%	83